Spruce Biosciences Inc (SPRB-Q) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr06/2024	Next Qtr09/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	-0.32	-0.32	-1.33	-1.13
Number of Estimates	3	3	4	4
High Estimate	-0.29	-0.29	-1.15	-0.58
Low Estimate	-0.34	-0.34	-1.59	-1.87
Prior Year	-0.32	-0.30	-1.24	-1.33
Growth Rate Est. (year over year)	unch	-6.67%	-7.26%	+15.04%

Earnings History - Surprises*

	Qtr Ending03/2024	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023
Reported	$-0.28	$-0.23	$-0.30	$-0.32
Estimate	$-0.32	$-0.41	$-0.34	$-0.37
Difference	+0.04	+0.18	+0.04	+0.05
Surprise	+12.50%	+43.90%	+11.76%	+13.51%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.83

3 Mths Ago6

3.57

2 Mths Ago7

3.57

1 Mth Ago7

3.57

Current7

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	6	7	7	7
	5 1	2	2	2
Holds	0	5	5	5

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Here’s the real reason your Canadian stocks can’t keep up

Premarket: Global stocks drift after Fed officials hint interest rates may not fall soon

number cruncher

U.S technology stocks with earnings and price momentum

Lightspeed Commerce stock soars on better-than-expected profit forecast

GameStop, AMC dive further as meme stocks rally tapers off

The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings

Proxy advisers recommend investors vote ‘no’ on Shopify executive pay

The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets